v3.26.1
Intangible Assets (Tables)
6 Months Ended
Jun. 30, 2026
Intangible Assets [Abstract]  
Schedule of Intangible Assets

Intangible assets consisted of the following:

 

Intangible Assets   June 30,
2026
    December 31,
2025
 
Licenses            
Non-Exclusive License Agreement   $ 179,821     $ 179,821  
Various generic drugs     -       736,983  
Four generic drugs (Encore)     -       1,308,270  
Needleless Syringe License     26,060       26,060  
Patents     48,420       48,420  
Mineral exploration rights and exploration licenses     48,416,474       -  
Total intangible assets, net   $ 48,670,775     $ 2,299,554